Urology Devices Market

Urology Devices Market Research Report By Product Type (Endoscopy Devices, Litotripters, Dialysis Equipment, Prostate Devices, Catheters), By Application (Diagnosis, Therapy, Surgery), By End User (Hospitals, Clinics, Home Care Settings), By Distribution Channel (Direct Sales, Distributors, Online Sales) and By Region (North America, Europe, South America, Asia Pacific, Middle East and Africa) -Forecast to 2035
ID: MRFR/HC/0614-HCR
200 Pages
Nidhi Mandole, Rahul Gotadki
Last Updated: June 01, 2026
Urology Devices Market Infographic
Request Free Sample

Urology Devices Market Summary

The Global Urology Devices Market size was valued at USD 39.6 Billion in 2024, and the market is projected to grow from USD 42.6 Billion in 2025 to USD 83.0 Billion by 2035, registering a CAGR of 7.7% during the forecast period 2025–2035. North America led the market with over 23.5% share, generating around USD 9.30 Billion in revenue. North America led the market with over 59.34% share, generating around USD 23.5 billion in revenue.
 
The increasing prevalence of urological disorders, including urinary incontinence, kidney stones, benign prostatic hyperplasia, and prostate cancer, is a major growth driver for the Urology Devices Market. Rising diagnosis rates, aging populations, and demand for minimally invasive treatments continue accelerating device adoption globally.
 
According to WHO, the global population aged 60 years and older is projected to reach 2.1 billion by 2050, significantly expanding the population vulnerable to age-related urological conditions and supporting sustained demand for advanced diagnostic and therapeutic urology devices.

Key Market Trends & Highlights

The Urology Devices Market is experiencing robust growth driven by technological advancements and increasing healthcare investments.

  • North America led the Urology Devices Market with over 59.34% of global revenue in 2024.
  • Europe Urology Devices Market reached USD 12.5 billion in 2024, accounting for approximately 31.57% global market share.
  • Diagnostic Devices led the application segment with approximately 42% share in 2024, driven by increasing demand for early diagnosis.
  • Hospitals accounted for nearly 58% of market revenue in 2024, supported by high patient volumes and specialized care.
  • Robotic Surgery captured approximately 41% technology share in 2024, reflecting growing adoption of minimally invasive procedures.
  • Adult Males represented around 54% of market demand in 2024, owing to increasing prevalence of prostate-related disorders.

Market Size & Forecast

2025 Market Size 39.6 (USD Billion)
2035 Market Size 83.0 (USD Billion)
CAGR (2026 - 2035) 7.7%

Major Players

Companies such as Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Coloplast A/S (DK), Teleflex Incorporated (US), Stryker Corporation (US), Cook Medical (US), Ferring Pharmaceuticals (CH) are some of the major participants in the Urology Devices Market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Urology Devices Market Trends

The Urology Devices Market is currently experiencing a transformative phase, characterized by advancements in technology and an increasing prevalence of urological disorders. The integration of minimally invasive techniques and robotic-assisted surgeries is reshaping treatment paradigms, leading to enhanced patient outcomes and reduced recovery times. Furthermore, the growing awareness of urological health among the population is driving demand for innovative devices, which are becoming more accessible and user-friendly.

This shift is likely to foster a competitive landscape where manufacturers are compelled to invest in research and development to meet evolving consumer needs. In addition, the Urology Devices Market is witnessing a surge in the adoption of telemedicine and digital health solutions. These technologies facilitate remote monitoring and consultations, thereby improving patient engagement and adherence to treatment plans. As healthcare systems worldwide adapt to these changes, the market is poised for sustained growth. The emphasis on personalized medicine and tailored therapies may further influence the trajectory of this sector, suggesting a future where urology devices are increasingly customized to individual patient profiles.

Technological Advancements

The Urology Devices Market is seeing rapid technological innovations, particularly in robotic-assisted surgeries and minimally invasive procedures. These advancements enhance precision and reduce recovery times, appealing to both healthcare providers and patients.

  • Medtronic continues advancing product development and innovation through robotic-assisted surgery platforms and minimally invasive urology technologies. Strategic collaborations with healthcare institutions and research organizations support next-generation surgical solutions that enhance procedural precision, reduce recovery times, and improve patient outcomes. These innovations are accelerating adoption of advanced urology devices across hospitals and specialty centers globally.

Increased Awareness and Education

There is a growing emphasis on urological health education, leading to heightened awareness among the general population. This trend is likely to drive demand for urology devices as individuals become more proactive in seeking treatment.

  • Johnson & Johnson MedTech has strengthened its portfolio through acquisitions and expansion initiatives supporting advanced surgical and diagnostic technologies. Regulatory approvals and ongoing clinical advancements continue improving treatment accessibility and physician confidence. Increased educational initiatives regarding urological health are encouraging earlier diagnosis and intervention, supporting growing demand for innovative urology devices and treatment solutions.

Telemedicine Integration

The incorporation of telemedicine into urology practices is transforming patient care. Remote consultations and monitoring are becoming commonplace, improving access to care and patient engagement in their treatment journeys.

  • B. Braun Melsungen AG continues investing in product innovation supporting digital healthcare integration and patient monitoring solutions. Regulatory-compliant technologies and ongoing clinical advancements are helping expand tele-urology capabilities, enabling remote consultations and continuous patient management. These developments improve healthcare accessibility, strengthen patient engagement, and support broader adoption of connected urology care models worldwide.

Urology Devices Market Drivers

Market Growth Projections

The Global Urology Devices Market Industry is projected to experience substantial growth over the coming years. With an estimated market value of 39.6 USD Billion in 2025, it is anticipated to reach 83.0 USD Billion by 2035. This growth reflects a compound annual growth rate (CAGR) of 7.7% from 2026 to 2035.
 
Such projections indicate a robust demand for urology devices, driven by factors such as technological advancements, rising healthcare expenditure, and an increasing prevalence of urological disorders. The market's expansion is likely to create opportunities for manufacturers and healthcare providers alike.
 

  • World Bank data show global healthcare expenditure continues rising across developed and emerging economies, supporting investments in advanced diagnostic and therapeutic technologies. Increased healthcare funding is strengthening hospital infrastructure and expanding access to specialized urological care, supporting long-term market growth.

Growing Awareness and Education

Enhanced awareness and education regarding urological health contribute to the expansion of the Global Urology Devices Market Industry. Campaigns aimed at educating the public about urological disorders and available treatments encourage individuals to seek medical advice and intervention.
 
Organizations and healthcare providers are increasingly focusing on outreach programs that highlight the importance of early diagnosis and treatment. This growing awareness is likely to lead to higher demand for urology devices, as patients become more informed about their options and the benefits of seeking timely care.
 

  • PubMed studies indicate that public awareness campaigns and educational interventions significantly improve screening participation and early diagnosis rates for urological disorders. Increased patient awareness supports greater utilization of diagnostic procedures and treatment devices, contributing positively to market expansion.

Increasing Healthcare Expenditure

Rising healthcare expenditure across various regions positively influences the Global Urology Devices Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes the procurement of advanced urology devices.
 
For instance, countries with robust healthcare systems, such as the United States and Germany, allocate significant portions of their GDP to healthcare, facilitating access to innovative urology treatments. This trend is expected to bolster the market, as higher spending correlates with improved healthcare services and increased availability of urology devices, ultimately supporting the market's growth trajectory.
 

  • According to World Bank health expenditure indicators, healthcare spending exceeds 10% of GDP in several developed economies. Sustained investments in healthcare infrastructure and medical technologies continue improving access to advanced urological diagnostics and treatment procedures.

Aging Population and Lifestyle Changes

The aging population, coupled with lifestyle changes, plays a crucial role in shaping the Global Urology Devices Market Industry. As individuals age, they are more susceptible to urological conditions, which are often exacerbated by lifestyle factors such as obesity and sedentary behavior.
 
The demographic shift towards an older population, alongside increasing rates of obesity, suggests a heightened need for urology devices. This trend is expected to drive market growth, as healthcare systems adapt to meet the needs of an aging population, thereby increasing the demand for urological interventions.
 

  • IHME data indicate that age-related conditions and obesity-associated health burdens continue increasing globally. The growing elderly population and rising prevalence of metabolic disorders are expanding the patient pool requiring diagnosis and treatment of urological diseases.

Rising Prevalence of Urological Disorders

The increasing incidence of urological disorders globally drives the Global Urology Devices Market Industry. Conditions such as urinary incontinence, benign prostatic hyperplasia, and kidney stones are becoming more prevalent, particularly among aging populations.
 
For instance, the World Health Organization indicates that the global population aged 60 years and older is projected to reach 2.1 billion by 2050, which correlates with a rise in urological conditions. This demographic shift suggests a growing demand for urology devices, contributing to the market's projected value of 7.52 USD Billion in 2024 and an anticipated growth to 11.5 USD Billion by 2035.
 

  • IHME estimates show millions of individuals worldwide are affected by urinary tract disorders, kidney diseases, and prostate-related conditions annually. The increasing disease burden continues driving demand for advanced urology devices and minimally invasive treatment technologies.

Technological Advancements in Urology Devices

Innovations in medical technology significantly enhance the Global Urology Devices Market Industry. The introduction of minimally invasive surgical techniques and advanced imaging technologies has improved patient outcomes and reduced recovery times.
 
For example, robotic-assisted surgeries and laser lithotripsy have revolutionized treatment approaches, making procedures safer and more efficient. These advancements not only attract healthcare providers but also encourage patients to seek treatment, thereby expanding the market. As technology continues to evolve, it is likely that the market will experience sustained growth, with a projected CAGR of 3.94% from 2025 to 2035.
 

  • PubMed research demonstrates that robotic-assisted urological procedures improve surgical precision, reduce blood loss, and shorten hospital stays compared with conventional approaches. Continued innovation in minimally invasive technologies is strengthening adoption across healthcare facilities globally.

Market Segment Insights

By Application: Diagnostic Devices (Largest) vs. Therapeutic Devices (Fastest-Growing)

In the Urology Devices Market, the application segment is notably dominated by Diagnostic Devices, which capture 42% portion of the market share. This is largely due to growing awareness and advancements in imaging technologies, leading to increased demand for effective diagnostic tools in urology. In contrast, Therapeutic Devices are rapidly gaining traction and show promise for higher growth rates, driven by the ongoing development of innovative treatment options and enhanced procedural techniques.

Medtronic continues investing in advanced diagnostic technologies supporting early detection and management of urological disorders. Diagnostic Devices accounted for approximately 42% of market revenue in 2024, reflecting strong demand for accurate imaging, monitoring, and assessment tools across healthcare settings.

By End Use: Hospitals (Largest) vs. Clinics (Fastest-Growing)

In the Urology Devices Market, the end use segments exhibit a diverse range, with hospitals taking the lead with 58% market share. Hospitals dominate due to their extensive patient base and comprehensive urological care services, ensuring a consistent demand for advanced urology devices. Clinics follow as a rapidly growing segment, benefiting from the shift towards outpatient care and increased patient access to urological consultations and treatments.

Johnson & Johnson MedTech continues expanding hospital-focused surgical and diagnostic portfolios through innovation and clinical advancements. Hospitals represented approximately 58% of market demand in 2024, driven by high patient volumes, specialized expertise, and comprehensive urological treatment capabilities.

By Product Type: Urodynamic Devices (Largest) vs. Kidney Stone Management Devices (Fastest-Growing)

In the Urology Devices Market, the distribution of market share illustrates that Urodynamic Devices represent the largest portion with 36% market share, benefiting from a strong demand for diagnostics and treatment options associated with urinary disorders. Endourology Devices and Prostate Health Devices also hold significant shares, reflecting the growing need for minimally invasive surgical procedures and advanced therapeutic options amidst a rising patient population with prostate-related ailments and urinary issues.

Urodynamic Devices (Dominant) vs. Kidney Stone Management Devices (Emerging)

Urodynamic Devices are at the forefront of the Urology Devices Market, providing essential diagnostic capabilities for various urinary tract disorders. Their dominance is driven by widespread use in urological evaluations, including bladder function tests, which are critical for effective treatment planning. On the other hand, Kidney Stone Management Devices are emerging rapidly, propelled by increasing incidences of kidney stones and advancements in non-invasive technologies. As the prevalence of kidney stones rises globally, innovation in treatment devices such as laser lithotripsy tools and ureteroscopes is expected to accelerate, positioning this segment for significant growth in the coming years.

By Technology: Robotic Surgery (Largest) vs. Telemedicine (Fastest-Growing)

In the Urology Devices Market, the technology segment is characterized by a diverse array of innovations, predominantly led by Robotic Surgery. This method has captured a 41% portion of the market, primarily due to its precision, reduced recovery time, and lower complication rates. Laser Technology and Minimally Invasive Surgery also contribute meaningfully, but Robotic Surgery remains the preferred choice for many healthcare providers, enhancing surgical outcomes through advanced analytics and real-time imaging. As the market evolves, Telemedicine is rapidly emerging as a transformative force, driven by the need for accessible care and advancements in digital health technologies. The shift to remote consultations and care has accelerated, particularly post-pandemic, further enhancing patient engagement and convenience. Thus, while Robotic Surgery holds a dominant position, Telemedicine's swift growth underscores changing patient needs in the Urology landscape.

Technology: Robotic Surgery (Dominant) vs. Telemedicine (Emerging)

Robotic Surgery has established itself as the dominant innovation within the Urology Devices Market, being associated with high precision and minimal invasiveness, which attracts both surgeons and patients alike. The technology enhances surgical capabilities through improved visualization and dexterity, thereby increasing the efficiency of urological procedures. On the other hand, Telemedicine is rapidly gaining traction as an emerging solution for patient care in urology, providing the convenience of remote consultations. This technology facilitates continuous monitoring and follow-up, which is particularly beneficial for chronic urological conditions. Both segments represent significant advancements, with Robotic Surgery being highly specialized for complex interventions, while Telemedicine prioritizes accessibility, thereby catering to a wider patient demographic.

By Patient Demographics: Adult Males (Largest) vs. Geriatric Patients (Fastest-Growing)

In the Urology Devices Market, Adult Males represent the largest demographic, accounting for 54% portion of the market share due to the prevalence of urological conditions among men. This segment encompasses a variety of disorders such as benign prostatic hyperplasia and prostate cancer, which drive demand for diagnostic and treatment devices. Meanwhile, Geriatric Patients are emerging as a rapidly growing segment within the market, primarily due to the aging population and the increase in urological ailments related to age, thereby contributing markedly to market dynamics.

Adult Males (Dominant) vs. Geriatric Patients (Emerging)

The Adult Males segment is characterized by a well-established market presence, driven by the high incidence of conditions such as prostate-related issues and urinary tract infections. This demographic has historically been prioritized in the development of urology devices, leading to advanced technologies that cater specifically to male urological health. In contrast, Geriatric Patients represent an emerging group that is experiencing rapid growth due to demographic shifts and an increasing life expectancy. As the elderly population becomes more aware of their health issues, the demand for specialized urology devices is accelerating, prompting companies to innovate solutions tailored to the complexities of geriatric care.

Get more detailed insights about Urology Devices Market
Request Free Sample

Regional Insights

North America : Market Leader in Urology Devices

North America leads in the Urology Devices Market Size, accounting for over 23.5% of the global revenue in 2024. The region's growth is driven by increasing incidences of urological disorders, advancements in medical technology, and a robust healthcare infrastructure. Regulatory support and favorable reimbursement policies further catalyze market expansion, making it a prime area for innovation and investment. 

  • CDC statistics indicate that millions of Americans are affected annually by chronic kidney disease and urinary tract conditions, supporting strong demand for advanced diagnostic and therapeutic urology devices. Rising awareness and early screening initiatives continue enhancing treatment utilization across North America.

The competitive landscape in North America is characterized by the presence of major players such as Boston Scientific, Medtronic, and Johnson & Johnson. These companies are at the forefront of developing cutting-edge urology devices, enhancing patient outcomes. The U.S. remains the largest market, supported by high healthcare expenditure and a focus on research and development. This dynamic environment fosters continuous growth and attracts new entrants into the market.

  • GE Healthcare continues advancing imaging and digital health technologies that support earlier detection of urological disorders. Investments in AI-enabled diagnostic systems and precision imaging solutions are helping healthcare providers improve patient outcomes and operational efficiency.

Europe : Emerging Market with Growth Potential

Europe Urology Devices Market was valued at USD 12.5 billion in 2024, making it the second-largest regional market with a 31.57% share. The region benefits from an aging population, increasing awareness of urological health, and advancements in minimally invasive procedures. Regulatory frameworks are evolving to support innovation, which is expected to drive demand for new technologies and devices in the coming years.

  • The European Medicines Agency (EMA) continues supporting regulatory pathways for innovative medical technologies and therapies addressing urological disorders. Strengthened regulatory frameworks and increased focus on patient safety are encouraging adoption of advanced diagnostic and treatment devices across European healthcare systems.

Leading countries in this market include Germany, France, and the UK, where established healthcare systems and high patient volumes contribute to market expansion. Key players like B. Braun Melsungen AG and Coloplast A/S are actively investing in research and development to enhance their product offerings. The competitive landscape is robust, with a mix of established firms and emerging startups, fostering a dynamic environment for growth.

Asia-Pacific : Rapidly Growing Urology Market

The Asia-Pacific Urology Devices Market is on a growth trajectory, with a market size of $8.0 billion. Factors such as rising healthcare expenditure, increasing prevalence of urological diseases, and a growing awareness of advanced treatment options are driving this expansion. Additionally, government initiatives aimed at improving healthcare access are expected to further boost market growth in the region.

Countries like China, India, and Japan are leading the market, supported by a large patient population and increasing investments in healthcare infrastructure. The competitive landscape features both global players and local manufacturers, creating a diverse market environment. Companies like Teleflex and Cook Medical are focusing on expanding their presence in this region, enhancing their product portfolios to cater to local needs.

Middle East and Africa : Emerging Market with Challenges

The Middle East and Africa Urology Devices Market, valued at $2.39 billion, is gradually emerging as a significant player in the global landscape. Growth drivers include increasing healthcare investments, rising awareness of urological health, and a growing prevalence of urological disorders. However, challenges such as limited access to advanced healthcare facilities and varying regulatory environments may hinder rapid growth in certain areas.

Leading countries in this region include South Africa and the UAE, where healthcare reforms and investments are paving the way for market expansion. The competitive landscape is evolving, with both international and local companies striving to capture market share. Key players are focusing on strategic partnerships and collaborations to enhance their market presence and address local healthcare needs.

Key Players and Competitive Insights

The Urology Devices Market is characterized by a dynamic competitive landscape, driven by technological advancements, increasing prevalence of urological disorders, and a growing aging population. Major players such as Boston Scientific (US), Medtronic (US), and Johnson & Johnson (US) are strategically positioned to leverage innovation and expand their market presence. Boston Scientific (US) focuses on enhancing its product portfolio through continuous innovation, while Medtronic (US) emphasizes strategic partnerships to bolster its technological capabilities. Johnson & Johnson (US) adopts a multifaceted approach, integrating digital health solutions into its offerings, thereby shaping a competitive environment that prioritizes advanced technology and patient-centric solutions.
 
Key business tactics within the Urology Devices Market include localizing manufacturing and optimizing supply chains to enhance operational efficiency. The market structure appears moderately fragmented, with several key players exerting considerable influence. This fragmentation allows for a diverse range of products and services, fostering competition that drives innovation and quality improvements across the sector. In November 2025, Boston Scientific (US) announced the launch of its latest minimally invasive urological device, which is designed to improve patient outcomes and reduce recovery times.
 
This strategic move underscores the company's commitment to innovation and positions it favorably against competitors by addressing the growing demand for less invasive treatment options. The introduction of this device is likely to enhance Boston Scientific's market share and reinforce its reputation as a leader in urology solutions. In October 2025, Medtronic (US) entered into a strategic partnership with a leading telehealth provider to integrate remote monitoring capabilities into its urology devices. This collaboration aims to enhance patient engagement and streamline care delivery, reflecting a broader trend towards digital health integration.
 
By leveraging telehealth technologies, Medtronic (US) is poised to improve patient outcomes and expand its reach in the urology market, potentially setting a new standard for patient care. In September 2025, Johnson & Johnson (US) unveiled a new AI-driven analytics platform designed to optimize the performance of its urology devices. This platform aims to provide healthcare professionals with actionable insights, thereby improving clinical decision-making. The introduction of AI technology signifies a shift towards data-driven solutions in the urology sector, positioning Johnson & Johnson (US) at the forefront of innovation and enhancing its competitive edge.
 
As of December 2025, current competitive trends in the Urology Devices Market are increasingly defined by digitalization, sustainability, and the integration of AI technologies. Strategic alliances are becoming pivotal in shaping the landscape, as companies seek to enhance their technological capabilities and expand their market reach. The competitive differentiation is likely to evolve from traditional price-based competition towards a focus on innovation, advanced technology, and supply chain reliability, indicating a transformative shift in how companies compete in this sector.

Key Companies in the Urology Devices Market include

Industry Developments

Recent developments in the Global Urology Devices Market have seen significant advancements and strategic movements among key players. In September 2023, Boston Scientific announced the expansion of its urology product portfolio by launching a new minimally invasive treatment technology aimed at improving patient outcomes. Moreover, in August 2023, Medtronic unveiled its latest robotic-assisted surgical device tailored for urological procedures, enhancing precision and efficiency. In the area of mergers and acquisitions, in July 2023, Teleflex completed its acquisition of a leading urology company, further solidifying its market presence. 

Additionally, in December 2022, Coloplast also acquired an innovative urology device manufacturer to expand its product offerings, capturing a larger market share. The growth in the market valuation of companies like Stryker and Fresenius Medical Care has been notable, driven by an increasing demand for advanced urology solutions. Over the past couple of years, significant shifts in regulations and reimbursement policies have impacted market players, prompting firms like Johnson and Johnson and Baxter International to align their strategies accordingly to maintain competitiveness in a rapidly evolving landscape.

Future Outlook

Urology Devices Market Future Outlook

The Urology Devices Market size is projected to reach USD 83.0 Billion by 2035, growing at a CAGR of 7.7%.

New opportunities lie in:

  • Development of minimally invasive robotic surgical systems Expansion of telehealth platforms for urology consultations Investment in AI-driven diagnostic tools for early disease detection

By 2035, the Urology Devices Market is expected to achieve substantial growth and innovation.

Market Segmentation

Urology Devices Market End Use Outlook

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Home Care Settings

Urology Devices Market Technology Outlook

  • Robotic Surgery
  • Laser Technology
  • Minimally Invasive Surgery
  • Telemedicine

Urology Devices Market Application Outlook

  • Diagnostic Devices
  • Surgical Devices
  • Therapeutic Devices
  • Monitoring Devices

Urology Devices Market Product Type Outlook

  • Urodynamic Equipment
  • Endoscopes
  • Catheters
  • Stents

Urology Devices Market Patient Demographics Outlook

  • Adult
  • Pediatric
  • Geriatric

Report Scope

MARKET SIZE 2025 39.6(USD Billion)
MARKET SIZE 2026 42.6(USD Billion)
MARKET SIZE 2035 83.0(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 7.7% (2026 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2025
Market Forecast Period 2026 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Boston Scientific (US), Medtronic (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Coloplast A/S (DK), Teleflex Incorporated (US), Stryker Corporation (US), Cook Medical (US), Ferring Pharmaceuticals (CH)
Segments Covered Application, End Use, Product Type, Technology, Patient Demographics
Key Market Opportunities Integration of advanced robotics and minimally invasive techniques in the Urology Devices Market.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the Urology Devices Market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the current valuation of the Urology Devices Market as of 2024?

The Urology Devices Market was valued at 46.39 USD Billion in 2024.

What is the projected market valuation for the Urology Devices Market in 2035?

The market is projected to reach 420.9 USD Billion by 2035.

What is the expected CAGR for the Urology Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Urology Devices Market during 2025 - 2035 is 22.2%.

Which companies are considered key players in the Urology Devices Market?

Key players in the market include Boston Scientific, Medtronic, Johnson & Johnson, Bard Medical, Coloplast, Stryker, Teleflex, Cook Medical, and Ferring Pharmaceuticals.

What are the main segments of the Urology Devices Market by application?

The main segments by application include Diagnostic Devices, Surgical Devices, Therapeutic Devices, and Monitoring Devices.

How much was the market size for Therapeutic Devices in 2024?

The market size for Therapeutic Devices was 15.56 USD Billion in 2024.

What is the projected market size for Endourology Devices by 2035?

The market size for Endourology Devices is projected to reach 90.0 USD Billion by 2035.

Which end-use segment had the highest valuation in 2024?

In 2024, the Hospitals segment had the highest valuation at 18.55 USD Billion.

What is the market size for Prostate Health Devices as of 2024?

The market size for Prostate Health Devices was 16.39 USD Billion in 2024.

What technological advancements are influencing the Urology Devices Market?

Technological advancements such as Robotic Surgery, Laser Technology, Minimally Invasive Surgery, and Telemedicine are influencing the market.

Author
Author
Author Profile
Nidhi Mandole LinkedIn
Senior Research Analyst
She is an extremely curious individual currently working in Healthcare and Medical Devices Domain. Nidhi is comfortably versed in data centric research backed by healthcare educational background. She leverages extensive data mining and analytics tools such as Primary and Secondary Research, Statistical Analysis, Machine Learning, Data Modelling. Her key role also involves Technical Sales Support, Client Interaction and Project management within the Healthcare team. Lastly, she showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Get In Touch
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, peer-reviewed medical journals, clinical publications, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) Medical Device Databases, European Medicines Agency (EMA) Medical Device Regulations, China National Medical Products Administration (NMPA), Pharmaceuticals and Medical Devices Agency (PMDA) Japan, Central Drugs Standard Control Organization (CDSCO) India, American Urological Association (AUA), European Association of Urology (EAU), International Continence Society (ICS), Society of Urologic Oncology (SUO), Endourological Society, National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Center for Health Statistics, United States Renal Data System (USRDS), European Renal Association (ERA) Registry, World Health Organization (WHO) Global Health Observatory, ClinicalTrials.gov, and national health ministry reports from key markets.

These sources were employed to gather procedure statistics, regulatory approval data (510(k), PMA, De Novo pathways), clinical safety studies, dialysis prevalence data, endoscopic procedure volumes, demographic trends, and market landscape analysis for dialysis devices, endoscopes & endovision systems, laser & lithotripsy systems, robotic surgical systems, urodynamic equipment, urinary catheters, stents, and other urological technologies.

 

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. The supply-side sources consist of CEOs, VPs of Product Development, regulatory affairs chiefs, and commercial directors from urology device manufacturers, dialysis equipment OEMs, endoscopy system providers, and robotic surgery platform developers. Board-certified urologists, endourologists, urologic oncologists, medical directors of dialysis centers, chiefs of procurement from hospital systems, specialty clinic practice managers, and ambulatory surgical center (ASC) administrators comprised demand-side sources. Primary research has confirmed the product pipeline timelines for minimally invasive and AI-integrated devices, validated market segmentation across kidney diseases, urological cancers, benign prostatic hyperplasia (BPH), urinary stones, and urinary incontinence, and gathered insights on clinical adoption patterns, robotic surgery penetration, dialysis center capacity expansion, pricing strategies, and reimbursement dynamics for disposable and capital equipment.

Primary Respondent Breakdown:

• By Designation: C-level Primaries (32%), Director Level (30%), Others (38%)

• By Region: North America (32%), Europe (30%), Asia-Pacific (28%), Rest of World (10%)

 

Market Size Estimation

Revenue mapping and procedure volume analysis were implemented to determine global market valuation. The methodology comprised the following:

• Identification of over 50 key manufacturers in North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa

• Product mapping for dialysis devices (hemodialysis and peritoneal), endoscopes (cystoscopes, ureteroscopes, resectoscopes), lasers and lithotripsy devices (holmium, thulium, ESWL), robotic surgical systems, urodynamic systems, urinary catheters, ureteral stents, and biopsy devices

• Examination of annual revenues that are reported and modeled for urological device portfolios, which includes aftermarket services and consumables

• In 2024, the coverage of manufacturers will account for 72-77% of the global market share.

• Segment-specific valuations for instruments and consumables and accessories are derived through extrapolation using bottom-up (procedure volume × ASP by country for dialysis sessions, stone management procedures, robotic prostatectomies, and continence interventions) and top-down (manufacturer revenue validation) approaches.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report

No regional reports available for this market.

Customer Stories

Case Study Cover Image
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.